The mainstay of treatment of vitiligo is-
## **Core Concept**
Vitiligo is a chronic autoimmune skin disorder characterized by the loss of melanocytes, leading to white patches on the skin. The mainstay of treatment aims to halt disease progression, promote repigmentation, and improve the appearance of the skin. Treatment options range from topical therapies to surgical interventions.
## **Why the Correct Answer is Right**
Topical corticosteroids are considered the first-line treatment for vitiligo due to their ability to suppress the autoimmune response and promote repigmentation. They work by reducing inflammation and modulating the immune system, thereby preventing further destruction of melanocytes. This approach is effective, especially in the early stages of the disease and in cases with limited skin involvement.
## **Why Each Wrong Option is Incorrect**
- **Option A:** While phototherapy, particularly narrowband UVB and PUVA, is an effective treatment for vitiligo, it is usually considered after topical treatments have failed or in cases with widespread disease. It's not typically the mainstay but rather a second-line treatment.
- **Option B:** Surgical interventions, including skin grafting and melanocyte transplantation, are usually reserved for patients with stable vitiligo who have not responded to medical treatments. These are not considered first-line treatments.
- **Option C:** Immunosuppressive drugs are sometimes used in severe cases of vitiligo, especially when there's significant morbidity or when other treatments have failed. However, due to their side effects, they are not the mainstay of treatment for most patients.
## **Clinical Pearl / High-Yield Fact**
A key point to remember is that early treatment of vitiligo is crucial for better outcomes. Topical corticosteroids are often the initial treatment of choice, especially for localized disease. Remember, "Corticosteroids are the cornerstone in the management of vitiligo."
## **Correct Answer:** . Topical corticosteroids.